Law firm Stephenson Harwood LLP has advised venture capital firm Augmentum Capital on the successful IPO of its first listed investment fund.
The new investment trust, Augmentum Fintech plc, raised £94 million. Its shares were admitted to the premium listing segment of the Official List of the FCA and to trading on the Main Market of the London Stock Exchange on 13 March 2018.
Hogan Lovells advised Simble Solutions Limited, an Australian enterprise Software as a Service company focused on business and resource management, on its successful initial public offering and listing on the Australian Securities Exchange.
The company successfully raised $7.5 million in a heavily oversubscribed offer at an issue price of 20 cents.
Eversheds Sutherland has advised Peel Hunt in its role as sole sponsor and bookrunner in connection with a £73 million firm placing, placing, open offer and offer for subscription by Regional REIT Limited, the listed UK regional office and industrial property focused REIT. Admission of the new ordinary shares became effective at 8am on 21 December 2017.
The team was led by corporate partner Sebastian Orton with assistance from Mark Roe (legal director), Harry Pangas (corporate partner – US securities) and Lily Tomkins (associate).
Sidley advised DSP Merrill Lynch Limited and Citigroup Global Markets India Private Limited in connection with a successful US$545 million qualified institutions placement by Idea Cellular Limited (Idea). Idea issued and allotted approximately 42.42 crore equity shares to qualified institutional buyers at an issue price of Rs 82.50 per equity share, aggregating to about Rs 3,500 crore. Idea stated that the issue witnessed interest from a global investor base with about 56 percent and 44 percent allocation to Indian and foreign investors, respectively.
Baker McKenzie advised Hudson Bay Capital Management on its convertible bond investment of up to 36 million euros in Visiomed Group.
Visiomed Group is a company listed on Euronext Growth Paris which specialises in the development and marketing of innovative connected medical devices.
The financing was structured as a private issuance of warrants for bonds convertible into shares with equity warrants attached (BEOCABSA).
Baker McKenzie advised Clean TeQ Holdings on its underwritten institutional placement to raise A$150m and issue a share purchase plan. Proceeds will be used to fund early works and long lead items to accelerate the development of its 100% owned Sunrise Nickel /Cobalt /Scandium operations, located 350km west of Sydney.
Baker McKenzie, with a team led by counsel Eugenio Muschio and with the coordination of partner Pietro Bernasconi, acted as transaction counsel and the only law firm involved in relation to issuance by Mediobanca International (Luxembourg) S.A of CHF 150 million senior preferred bond with maturity on 2 March 2023, under the EMTN Programme.
The bond has issued for the listing on the SIX Swiss Exchange and is guaranteed by Mediobanca - Banca di Credito Finanziario S.p.A.. The dealers of the issuance were Credit Suisse AG and Commerzbank.
Real Estate business venture GODEWIND Immobilien AG intends to list its shares on the Regulated Market of the Frankfurt Stock Exchange on 27 March 2018. International law firm Clifford Chance is advising GODEWIND on this transaction.
Travers Smith LLP has advised Zeus Capital Limited, as financial adviser, broker, joint global co-ordinator and bookrunner, Numis Securities Limited, as joint global co-ordinator and bookrunner and Stockdale Securities Limited, as sponsor, to JTC PLC (JTC), on its £310 million main market IPO. The IPO involved the conditional placing of £243.8 million of existing and new ordinary shares.
JTC is a leading global provider of administration services to fund, corporate and private clients.
Dechert LLP assisted Bryan Garnier & Co Ltd, as global coordinator, joint lead-manager and bookrunner, and RBC Europe Limited, as joint lead-manager and bookrunner, in relation to the €16 million public offering of Biom’Up. Biom’Up is a French company that specializes in surgical hemostasis. Its flagship product aims at simplifying surgical procedures in numerous specialties.